Skip to main content
PLOS One logoLink to PLOS One
. 2026 Oct 5;21(10):e0358880. doi: 10.1371/journal.pone.0358880

Implementation of the Trigger Checklist and assertive outreach to reduce drug-related harm in the Emergency Department: A realist evaluation

Michelle Beattie 1,¤a,*,#, Lesley Campbell 2,¤b,#, Bev Fraser 3,¤c,#, Anna Terje 1,¤a,#
Editor: Maria J Berghs4
PMCID: PMC13637928  PMID: 42832473

Abstract

Background

Drug-related harm is a major global public health concern, with opioids implicated in over 70% of drug-related deaths. Scotland reports the highest drug-related mortality rate in Europe, with remote and rural communities facing additional barriers to accessing harm reduction and treatment services. Assertive outreach is increasingly recognised as a key strategy to engage individuals at risk who are disconnected from traditional services. This study evaluates the use of a Trigger Checklist to identify and outreach individuals within 48 hours of referral in a rural Emergency Department (ED).

Methods

A realist evaluation explored how and why the Trigger Checklist works within the complexity of an ED setting. Guided by Pawson and Tilley’s framework, the evaluation followed three stages: theory gleaning, refining, and consolidation. Initial programme theories were developed using literature and advisory group input, then refined through 13 realist interviews with ED clinicians and outreach workers (OW). Data were analysed using Context-Mechanism-Outcome (CMO) configurations and linked to middle-range theories.

Results

Three programme theories emerged: (1) Confident decision-making, where certainty, conversational aids, ethical reasoning, and outreach worker prompts influenced checklist use; (2) Trusting relationships, shaped by OWs’ approachability, situational awareness, and mutual respect; and (3) Perceived value, driven by altruism, narrative feedback, and perceived reductions in ED visits. Relational coordination theory explained how shared goals, knowledge, and respect – reinforced by timely, accurate communication – enabled coordinated action. OW presence and recovery discussions were critical to foster confident and appropriate referrals among ED clinicians.

Conclusions

The Trigger Checklist can support timely outreach potentially reducing drug-related harm in rural ED settings, but its success depends on relational dynamics, perceived value, and organisational integration. To avoid checklist fatigue or tokenistic use, it should be embedded with the support of OWs who foster trust. These relationships will enhance use of the checklist as a meaningful intervention within complex care systems.

Introduction

Drug use is estimated to contribute to more than half a million deaths globally each year, with opioids implicated in almost 80% of these fatalities [1]. The incidence of fatal opioid overdoses is rising internationally [2]. Scotland currently reports the 19.1 drug-related deaths for every 100,000 people in Scotland. While this is a 13% decline compared with 2023, the rate was 3.6 times as high in 2024 than 2000 [3]. Despite inconsistencies in global data recording practices, Scotland continues to have a higher rate of drug-related deaths per million population than most countries internationally [4]. The harms associated with drug use extend beyond the individual, affecting families, communities, and placing significant strain on health and social care systems. Those living in remote and rural areas may face additional challenges arising from geographical barriers to service access, difficulties in recruiting specialist drug-recovery practitioners, and limitations in local digital infrastructure [5].

Reducing drug-related harm necessitates a multifaceted approach encompassing prevention, early intervention, harm reduction, and emergency response. Across Europe, harm reduction strategies have been widely implemented, including access to opioid agonist treatment (OAT), the distribution of naloxone for overdose reversal, provision of sterile injecting equipment, and the establishment of supervised consumption facilities, [4]. Despite variations in national approaches, there is a broad consensus within health policy frameworks that medication-assisted treatment (MAT) represents the most effective response to opioid dependence.

In the United States, recent legislative reforms have aimed to expand access to MAT by removing regulatory barriers and promoting provider education [6]. Canada’s national strategy similarly supports proactive identification of individuals at risk and the provision of MAT within a public health framework [7]. In the United Kingdom, the “All Our Health” [8,9] framework emphasises that every contact with health services is an opportunity to engage individuals in treatment, while Scotland has introduced national MAT Standards to improve consistency and access. Notably, Standard 3 states that “all people at high risk of drug-related harm are proactively identified and offered support to commence or continue MAT” [9].

Despite alignment across National and international policy, the practical challenge of identifying and engaging individuals at risk of drug-related harm in treatment remains significant. While there is recognition that the circumstances experienced by people who use drugs can be characterised by significant instability, which can impede consistent engagement with services [10,11], there is also growing awareness that structural barriers within health and social care systems contribute to this disconnect. These challenges are likely exacerbated in remote and rural communities. Fragmented organisational infrastructures, siloed service delivery, and limited interagency collaboration reduce opportunities for timely intervention. Addressing these issues is essential to improving access, retention, and outcomes in medication-assisted treatment and broader harm reduction efforts.

Assertive outreach is increasingly recognised as a critical strategy in reducing drug-related harm, particularly among people who are disengaged from traditional services and experience marginalisation. Individuals who use drugs often face systemic barriers – including stigma, criminal behaviour, disconnect from social supports and fragmented service provision – which diminishes access to statutory support [12,13]. The stigma associated with drug use is often amplified in rural communities, where close-knit social networks and limited anonymity can intensify the visibility of individuals who use drugs, exacerbating exclusion and reinforcing barriers to access support. A recent study found that individuals who use drugs and reside in remote or rural areas are at increased risk of experiencing non-fatal overdoses [14].

Proactive outreach aims to bridge the gap by identifying individuals at risk and connecting them with appropriate interventions in a timely manner. A programme in Boston successfully outreached people by situating their mobile recovery service in an area with high overdose rates [15]. Peer-led outreach models have also shown promise; peer support workers conceptualise harm reduction as both a life-saving intervention and a pathway to recovery, offering emotional and practical support grounded in lived experience [16,17]. These approaches emphasise the importance of low-threshold and culturally responsive outreach services that meet people where they are, both geographically and in their recovery journey.

A need to develop a process to outreach those at risk of drug-related harm in a timely manner in a remote and rural area of Scotland was identified by the high incidence of drug-related harm. The Caithness Drug and Alcohol Recovery Service undertook some improvement work in 2023 to create, test and implement a Trigger Checklist to identify and outreach people within 48 hours of referral from police custody, the Emergency Department (ED) and other community partners.

The Trigger Checklist includes two screening questions to determine harmful drug use, ten risk assessment questions, and a free text section for additional comments from the referrer. The tool uses a low threshold for determining risk of drug harm with assertive outreach initiated for a ‘yes’ response to either of the two screening questions and to any one of the 10 risk questions. Details of the initial testing and development are reported elsewhere [18]. During initial testing and development very few Trigger Checklists were received from the ED despite anecdotal evidence of missed opportunities. It is known that many people at risk of drug harm are frequent attenders in the ED due to an increase in their ill health and accidents associated with their high-risk behaviour [19]. This study aimed to identify the reasoning of ED clinicians in response to the Trigger Checklist that might explain why, how and for whom the checklist could optimise outreach for those at risk of drug-related harm in a remote and rural ED.

Methods

Evaluation design

Realist evaluation is well-suited to exploring how and why the Trigger Checklist works within the complexity of an Emergency Department. Grounded in the work of Pawson and Tilley [20], this approach assumes that reality operates across three layers: the empirical (what is observed), the actual (what happens), and the real (underlying mechanisms). This emphasis on ontological depth is particularly relevant as it enables exploration beyond surface-level metrics and investigates the unseen phenomena (for example staff reasoning, organisational culture, and contextual triggers) that shape implementation and effectiveness. By doing so, it offers a nuanced understanding of how the checklist activates change within a complex system, and why it may succeed in some contexts but not others. Realist Context-Mechanism-Outcome (CMO) configurations were used as a heuristic to make sense of causal explanations underpinning Trigger Checklist completion within the ED.

Developing a realist evaluation framework begins with articulating the programme theory—that is, specifying how an intervention is expected to generate its effects and the conditions under which these effects are likely to occur. Programme theories are typically informed by prior research, practitioner experience, and the assumptions held by intervention designers about the mechanisms through which change will unfold. A clear and explicit understanding of an intervention’s intended aims, processes, and outcomes is therefore essential from the outset [21]. Within a realist perspective, whether an intervention ‘works’ depends on the decisions and actions taken by the individuals involved. These responses are shaped by the resources, opportunities, or constraints introduced by the intervention itself [20].

The evaluation followed the realist stages of theory gleaning, theory refining, and theory consolidation [22]. Ethical approval was sought and obtained from the University of the Highlands and Islands (ID: ETH2425−0561). Initial theory gleaning drew on literature informed by one author’s previous master’s dissertation (LC) and tacit knowledge from members of the Project Advisory Group (see PAG membership in Box 1). This informed the development of initial programme theories (IPTs) using CMO configurations (S1 File. Initial CMOs to final CMOs). Theory refining was iterative and interactive, involving interviews with ED staff and several data meetings with the research team. Theory consolidation involved retroduction, the process of inferring the underlying mechanisms that must be operating, given the observed outcomes in a particular context, and linking revised programme theories and CMOs to middle-range theories, the context specific explanations that link mechanisms to observed outcomes.

Box 1 PAG Membership

  • Recovery Service Lead

  • Senior Charge Nurse ED

  • Person in Recovery

  • ED Consultant

  • Psychiatrist/ Lead for Recovery

  • Realist Expert (out with project team).

  • Research Project Lead

  • Post Doc Researcher

Service and setting

The rural community involved in this project has an adult population of 21,291, with the estimated prevalence of drug use in Scotland at 1.62% [23]. On average, 173 individuals are referred annually to the local recovery service, with approximately half of these referrals related to drug use. Applying the national prevalence rate to this community suggests that around 345 adults may be using drugs. This indicates that roughly three out of four people who use drugs in this area are not accessing treatment services. The nearest acute hospital is located over 100 miles away.

Drug use is closely associated with deprivation [24], and this community contains areas of significant deprivation. The locality has the highest rate of drug-related hospital admissions per capita within the Highland Health board area [25], further supporting the assumption that the recovery service is not currently reaching most people who use drugs. The Drug and Alcohol Recovery Service provide care for adults in the geographical area. The service is made up of a professional/ service lead nurse, three registered nurses and four outreach workers covering two separate towns. The service lead is a nurse prescriber and addictions consultant support is provided virtually.

Participants

There is no strict ‘rule of thumb’ for the number of realist interviews to be conducted as interview data does not need to reach ‘data saturation’ but rather achieve relevance and rigor [22]. Participants were purposively sampled to ensure sufficient breadth of experience of the Trigger Checklist to ensure they could refute, refine and create programme theories (See Box 2 for Participant Criteria and Final Sample). The aim was to recruit approximately 10 stakeholders for individual realist interviews, with 13 ultimately participating.

Box 2 Participant Criteria Sample

Outreach Worker 2
Paramedic 1
ED Senior Charge Nurse 1
ED Advanced Nurse Practitioner 1
ED Nurse 4
ED Doctor 2
ED Healthcare Support Worker 2
n = 13

Recruitment

Recruitment was facilitated through the Clinical Nurse Manager and the Drug and Alcohol Recovery Service Team Lead. They shared information about the study during relevant Emergency Department (ED) and Drug and Alcohol Recovery meetings, as well as at informal training sessions. Individuals who expressed an interest were sent a Participant Information Sheet via email with details to contact either the Research Assistant (AT) or the Project Lead (MB) to arrange an interview.

Data collection

Interviews were offered in person within the ED on specific dates, or remotely via Microsoft Teams or telephone at a mutually agreed date/time between 21/03/2025 to the 05/05/2025. Of the 13 interviews conducted, four were via Microsoft Teams, one via telephone, and eight were conducted in person. Written informed consent was obtained from all participants prior to data collection. All interviews were audio-recorded and professionally transcribed verbatim.

Interviews were guided by a semi-structured topic guide (S2 File) and facilitated using the teacher–learner approach to realist interviewing [22]. Using this approach, the interviewer introduced theories and assumptions about how the Trigger Checklist was thought to work (acting as the “teacher”), while the interviewee shared their perceptions and experiences of how the checklist operates in practice (acting as the “teacher” in turn). This cyclical exchange continued until all relevant IPTs were explored and no new theories emerged.

Data analysis

Initial Programme Theories (IPTs), developed from the literature and the PAG, were iteratively refined through ongoing dialogue between the research team and further engagement with the literature (theory refining). This process continued until consensus was reached on the most relevant IPTs—particularly those suitable for exploration through interviews with clinicians from the Emergency Department (ED) and outreach workers.

Data were coded in NVivo 14 (MB, AT) around IPT groupings, e.g., those that related to patient presentation were coded under ‘patient presentation.’ Transcript data were then used to further develop the codes, and annotations were made for each IPT around explanatory mechanisms, specifically evidence of reasoning or actions that affirmed, refuted or refined the IPTs. Within the mechanism codes, contexts and outcomes were highlighted to observe patterns in the data.

Given the interpretative nature of realist evaluation, reflexive practice was embedded throughout data analysis. The research team, comprising of academic and clinical members, met weekly during theory refinement and consolidation to discuss emerging findings and CMO development. Particular attention was given to retroductive reasoning, with discussion focused on exploring alternative explanations and identifying underlying mechanisms that could plausibly account for the observed outcomes in specific contexts. These discussions supported multiple perspectives and final consensus building.

Theory consolidation involved two researchers independently reviewing the final theories. Memos were written to document retroductive ideas, decisions, and integration of middle-range theories to help make sense of the data.

Results

The analysis identified three programme theories, each comprising of interrelated sub-themes. Rather than presenting these as linear or compartmentalised categories, the conceptual framework (S1 Fig) visually illustrates their interconnectedness, highlighting the dynamic relationships across contexts, mechanisms, and outcomes and the programme theories themselves.

Relational co-ordination

Relational coordination was identified as a helpful middle-range theory that underpinned the findings and supports the transferability of the findings to similar contexts. The theory posits that relationships are a vital conduit for effective coordination, facilitated through shared goals, shared knowledge and mutual respect [26]. While shared knowledge is common in healthcare settings, it is insufficient on its own to build and sustain relational coordination. The communication dimensions of frequency, timeliness, accuracy and problem solving mutually reinforce each other and are essential for maintaining effective relationships. For example, the frequency of OW visits to the ED enabled timely opportunities for knowledge exchange and problem solving, which in turn fostered trust between ED clinicians and OWs. When the aspects of shared goals, shared knowledge and respect are present, they provide a foundation for collective identity and coordinated action [26].

  1. Confident decision-making – including certainty, an aid to conversation, balancing risk and confidentiality and regular human prompts.

  2. Trusting relationships – characterised by approachable outreach workers (OW), their situational awareness, and the development of trust and mutual respect between OW and ED clinicians.

  3. 3. Perceived value – encompassing altruism, the value of narrative feedback, and the perception of reduced ED visits.

The following paragraphs present and explain each programme theory, along with the CMO configurations (S1 Table) and detail of alterations from initial CMOs to the final CMOs (S1 File).

Programme theory 1 – Confident decision-making: ED staff feel confident in their decision-making to use the Trigger Checklist when it is relevant to the patient presentation, is used as an aid to a patient conversation around drug-related harm and OW are present twice daily in the Emergency Department.

Programme theory one was developed from seven CMOs: certainty (CMOs 1–3), an aid to conversation (CMO 4), confidentiality breach versus harm (CMOs 5&6), and regular human prompt (CMO 7).

Certainty

The first sub-theme of confident decision-making highlights the importance of ED staff having certainty in identifying people who use drugs and in the appropriateness of referral, which influences whether they complete the Trigger Checklist. Data configurations revealed that ED staff were more likely to act when they recognised an increase in a person’s drug-related presentations—either due to concern for their welfare or familiarity from repeated attendances (CMO2, CMO3). This recognition signalled escalating drug-related harm and reinforced the appropriateness of referral decisions. Conversely, when patients presented with acute, potentially life-threatening conditions, staff often prioritised immediate clinical care, resulting in the Trigger Checklist not being completed (CMO1). An initial rival theory proposed that the severity of such conditions might prompt staff to complete the checklist more readily, as the urgency could act as a trigger for action. However, this initial theory was removed due to a lack of supporting data. This pattern suggests that personal familiarity and perceived escalation in risk of harm triggered emotional and professional responsibility, enhancing certainty in decision-making and prompting action to complete the TC.

Aid to conversation

Initial programme theories suggested that the number of questions within the TC could possibly be reduced due to the administrative burden on the ED clinicians (see CMOs deleted in S1 File: Initial CMOs to final CMOs). However, the ten risk-related questions remained important to the Trigger Checklist use. Staff adapted its use, treating it as a conversational guide rather than a rigid script. Many found that asking all questions directly could hinder rapport, so they used the checklist flexibly—sometimes deferring parts of the conversation or reframing questions to suit the situation (CMO4). Over time, staff recognised that the checklist enhanced their awareness of drug-related risks and supported more sensitive, patient-led discussions. Even when not fully completed, the checklist supported proactive engagement and informed decision-making by scaffolding sensitive, patient-led discussions around drug harm.

Confidentiality breach versus harm

The Trigger Checklist (TC) may be completed without a patient’s consent when a clinician determines that the level of vulnerability and risk justifies overriding the need for consent. This decision is guided by the Caldicott Guardian principles, particularly Principle 7, which states that the duty to share information for individual care is as important as the duty to protect [27].

Clinicians who were confident in applying these principles felt ethically justified in completing the TC without consent when concerned about significant drug-related harm (CMO5). For them, the decision was straightforward: preventing harm took precedence over maintaining confidentiality, enabling informed and ethically sound action. In contrast, clinicians less familiar with the Caldicott principles were more hesitant. Concerns about breaching confidentiality, damaging the therapeutic relationship, or facing litigation (CMO6) led some to avoid completing the TC altogether.

An initial programme theory suggested that including a statement on the TC reinforcing Caldicott Principle 7 might reduce anxiety around potential legal consequences. However, the data did not support this. Instead, the key mechanism was clinicians’ underlying beliefs – particularly their fear of litigation and their confidence in being able to justify their decisions. This suggests that knowledge of ethical and legal frameworks is not simply applied rationally; rather decisions are influenced by deeply held professional beliefs and historic education around fears of litigation.

Regular human prompt

Outreach workers (OWs) acted as timely, human prompts for busy ED staff, encouraging consideration of potential referrals and facilitating conversations, especially when clinicians were uncertain about whether to complete a Trigger Checklist (TC) (CMO7). These interactions often helped shift clinicians from hesitation to confidence, especially when discussing the likelihood or risk of drug-related harm. Engaging with a OW enabled staff to clarify risk, resolve doubts, and feel more assured in their decision as to the appropriateness of a TC completion.

Initially, the role of OWs was understood to be limited to visiting the ED twice daily to collect completed TCs. As a result, no initial context-mechanism-outcome (CMO) configurations were developed around their involvement. However, patterns in the data revealed their pivotal role in influencing clinician decision-making, leading to the development of this CMO.

Programme theory one illustrates how ED staff decision making in using the Trigger Checklist is shaped by their certainty in identifying drug-related harm, ethical clarity around confidentiality, and knowledge and support from outreach workers. The checklist functions not only as a referral tool but also as a flexible aid for sensitive conversations, with its use influenced by both clinical judgement and relational dynamics within the ED. Programme theory 2 further explains the important relationship between OW and ED clinicians and the impact for people who use drugs that attend the ED.

Programme theory 2 – Trusting relationship: When the OWs have high situational awareness, they can judge the right moment and approach to getting the Trigger Checklist completed by ED staff. A mutually respecting relationship between the ED staff and OWs enables knowledge sharing which ultimately benefits the person who takes drugs.

Programme theory two was developed from five CMOs: approachable OWs (CMO 8), situational awareness of the OW (CMO 9), trust (CMOs 10&11), and mutual respect (CMO 12).

Approachable outreach workers (OWs)

Patterns in the data revealed that the outreach workers (OWs) were consistently perceived as friendly, approachable, and supportive, which encouraged ED staff to engage with them about potentially drug-related patient presentations. Over time, these interactions fostered trusting relationships, enabling open and honest discussions about patients at risk of drug-related harm (CMO 8). ED staff also observed the compassionate and non-judgemental way OWs interacted with people who use drugs, which positively influenced their own perceptions and attitudes towards this group of people. Ultimately, the OWs’ approachability facilitated case conversations and supported more informed, person-centred decisions that led to the Trigger Checklist being (appropriately) completed.

Situational awareness of the OW

outreach workers (OWs) demonstrated strong situational awareness, enabling them to judge the right moments to engage ED staff about potential referrals (CMO9). Rather than interrupting busy clinicians they used their own judgement and observations, for example reviewing the ED whiteboard to identify and note names for referral for later discussion. They also supported ED staff by helping complete the Trigger Checklist when needed. Importantly, the OWs’ understanding of the ED environment helped build strong relationships with ED staff—relationships that were essential to ensuring the Trigger Checklist was completed. Their situational awareness, timing, and collaborative approach fostered trust, enabling more timely and person-centred decisions around drug-related harm. These CMOs emerged from the data, as the initial programme theories did not anticipate the OWs’ active role. At the outset, the intervention was perceived as limited to the Trigger Checklist itself, with OWs simply collecting completed forms. The data revealed their influence to be far more significant.

Trust

In this rural emergency department building a trusting relationship between staff and individuals presenting with drug-related issues is crucial for eliciting honest disclosures. Individuals may withhold information due to fear of judgment, shame, or concerns that their responses could lead to unwanted consequences such as family involvement, police action, or social services intervention—especially when there is a general mistrust of those who work in public services (CMO 10). However, when an outreach worker (OW) is present or when ED staff take time to build rapport, individuals begin to feel safer and more confident, which fosters trust and encourages more open and honest communication. The initial CMO identified the mechanism of fear but was revised to incorporate the mitigation enacted in the presence of the OW.

Similarly, in close-knit rural communities, trust between ED staff and OSWs takes time to develop but is essential for legitimising the sharing of sensitive information. This mutual trust ensures that disclosures are made with the understanding that information will be handled respectfully and remain within the bounds of care services, which increases the completion of Trigger Checklists, ultimately improving outcomes for those at risk of drug-related harm (CMO 11). Again, the importance of a trusting relationship between the OW and ED staff only became apparent following data collection, hence a new CMO.

Mutual respect

Interview data revealed a strong pattern of mutual respect between emergency department (ED) staff and outreach workers (OWs), with each valuing the other’s expertise in supporting people who use drugs. This mutual respect fosters a collaborative environment for shared knowledge and each professional’s contribution is recognised as essential to holistic care. When ED staff and outreach workers appreciate and respect each other’s distinct roles, it legitimises their shared efforts and strengthens trust, enabling sensitive information to be communicated appropriately. This respectful partnership ensures that patients receive timely physical care in the ED and are seamlessly connected to follow-up support through outreach services like DARS, ultimately improving outcomes for those at risk of drug-related harm (CMO 12).

Programme theory two unearths how trusting relationships between outreach workers (OWs) and Emergency Department (ED) staff enable effective use of the Trigger Checklist (TC) for patients at risk of drug-related harm. Developed from five CMOs, it highlights how OWs’ approachability, situational awareness, and mutual respect foster collaboration. OWs were consistently seen as friendly and non-judgemental, encouraging ED staff to engage in open discussions. Their ability to judge the right moment to approach staff, often by observing the ED environment, built trust and supported timely TC completion. In rural settings, trust between staff and patients was also critical, as fear and stigma often hindered disclosure. OWs helped mitigate these barriers, creating safer spaces for honest communication. Initially, the intervention was seen as checklist-only, but data revealed OWs played a pivotal role in ED staff completing the Trigger Checklist.

Programme theory 3 – Perceived value: ED staff are more inclined to complete the Trigger Checklist when they feel an intrinsic motivation and desire to support individuals at risk of drug-related harm beyond what standard emergency care provides. Their motivation increases when they perceive the checklist as a valuable tool- especially when they observe fewer attendances and receive narrative feedback from OWs about individuals who have been successfully supported.

Altruism (CMO 13 and 14)

In this rural emergency department, altruism played a pivotal role in motivating staff to complete the Trigger Checklist for individuals presenting with potentially drug-related issues. When ED staff have experienced serious outcomes—such as a death or non-fatal overdose—the emotional impact deepens their empathy and reinforces the importance of early intervention. These experiences serve as powerful reminders of the value of proactive outreach in preventing future harm and prompt them to complete the Trigger Checklist (CMO 13). This was identified as an initial CMO but revised to incorporate the mechanism of value, as ED staff were clear that they were completing the checklist as they perceived it to be valuable.

Additionally, there was widespread recognition that people at risk of drug-related harm usually required additional interventions not provided by an ED. Clinicians were often limited in what they could offer so when ED staff had a clear and accessible referral process, completing the checklist became a meaningful act of care in a setting where long-term interventions are often limited. The combination of empathy and a desire to support vulnerable individuals drove staff to engage with the Trigger Checklist (CMO 14) not just as a procedural task, but as a compassionate response to reduce the trauma of drug-related harm for the individual, the clinician and the wider community.

Value of narrative feedback (CMO 15 & 16)

Initial programme theories proposed that visually presenting quantitative process and outcome data in the ED (possibly as run charts) would motivate staff to complete the TC. However, patterns in the data revealed a different reality for most. Rather than encouraging engagement, such displays can even undermine the intervention’s purpose. When ED staff perceived these metrics as driven by managerial agendas, they felt their clinical autonomy was being compromised and that the complexities of frontline care were misunderstood. This perception can foster resentment and reduce engagement with the TC, which becomes associated with oversight and compliance rather than compassionate care (CMO15). Although run charts showing TC compliance and outcomes were not displayed in the ED, some staff expressed concern that such tools could be interpreted as tools for judgement rather than support, shifting the intervention’s focus away from reducing drug-related harm.

In contrast, narrative feedback—particularly when shared by outreach workers (OWs)—can powerfully reaffirm the value of the Trigger Checklist. When ED staff hear real-life case studies that illustrate how their actions have contributed to a person’s recovery journey, it reinforces the Trigger Checklist as a meaningful and effective tool. These stories evoke empathy, validate the clinician’s role in a broader continuum of care, and highlight the tangible impact of their efforts. This kind of feedback fosters a sense of purpose and connection, motivating staff to continue using the checklist not out of obligation, but from a genuine desire to support individuals at risk (CMO 16). Narrative feedback appeared to shift the perception of the checklist from a procedural task into a relational and meaningful intervention of value.

Perception of less ED visits

When ED staff noticed that individuals with drug-related issues were attending less frequently, they attributed this change to the impact of the Trigger Checklist and associated outreach, reinforcing their belief in its value as a meaningful intervention rather than just a tick-box exercise (CMO 17). This shift in perception strengthens their motivation to use the checklist consistently, driven by a belief in its capacity to support recovery and reduce harm. It is worth noting that this was not driven by any formal statistics on attendance that ED staff had access to, but merely their own observations and anecdotal information. The initial CMO was revised to capture that the mechanism of reaffirming value to the person reflected the data better as compared to ED staff being hopeful that it would reduce the demand on the service.

Discussion

The aim of this realist evaluation was to explore the reasoning behind emergency department (ED) clinicians’ responses to the Trigger Checklist, in order to understand why, how, and for whom the checklist could facilitate timely outreach for individuals at risk of drug-related harm attending a remote and rural ED. Analysis generated three programme theories: (1) confident decision-making to identify and refer; (2) trusting relationships between outreach workers (OWs) and ED staff; and (3) perceived value of the Trigger Checklist and its associated outreach. These theories were underpinned by the middle-range theory of relational coordination.

This study found that implementing the Trigger Checklist within a remote and rural ED can support the identification and assertive outreach of individuals most at risk of drug-related harm. However, its effectiveness is closely linked to the strength of the relationship between OWs and ED staff. We found that OWs are a critical component of the intervention pathway; in their absence, the utility of the Trigger Checklist in rural ED settings would likely be significantly reduced. In addition, relational coordination between the OWs and ED staff was foundational to the effective operationalising of the Trigger Checklist within the ED. For example, in time-pressured situations where there was uncertainty about whether completing the Trigger Checklist was appropriate, busy ED staff often chose not to due to the necessity to quickly attend to the next patient. However, when the OWs attended the ED to collect completed checklists, their presence acted as a visual prompt and created opportunities for case discussions with ED staff. OW shared their knowledge and experience of working with people in recovery, which informed the clinician’s decision as to the appropriateness of the referral.

The use of visual management tools [28] and human prompts [29] is well established in healthcare to support and direct decision-making. This study found that combining both the visual prompt with human interaction enhanced the likelihood of the ED clinician completing the Trigger Checklist. This is a critical finding, as it challenges assumptions around efficiency driven solutions, such as online referrals which would have undermined a key mechanism initiating Trigger Checklist completions. Specifically, removing the OWs from the process in favour of online submissions would likely compromise the intervention’s impact. Instead, the success of the checklist was contingent on strong interpersonal relationships, sustained through key aspects of communication; frequency, timeliness, accuracy, and problem-solving—core elements of relational coordination [26].

This study observed patterns of behaviour which identified that the Trigger Checklist was not a universal screening tool, like Alcohol Brief Interventions, but rather a tool to be used when relevant to the patient’s presentation. This aligns well with the principles of autonomous clinical decision-making and person-centred care. Evidence supports the assertion that checklists do aid, but do not replace clinical decision-making [30,31].

An initial programme theory proposed that including a statement reinforcing Caldicott Principle 7—emphasising the duty to share information when appropriate—might alleviate clinician anxiety around legal consequences. However, patterns in the data did not support this assumption. Instead, the key mechanism influencing use of the Trigger Checklist was clinicians’ underlying beliefs, particularly their fear of litigation and their confidence in being able to justify their decisions. This finding aligns with existing literature on defensive medicine, which shows that fear of legal repercussions often drives clinical behaviour more strongly than ethical guidance [32,33].

Data sharing and legal concerns continue to present significant barriers to connecting siloed services across health and social care [34–36]. Despite the existence of ethical frameworks such as the Caldicott Principles, clinicians often remain uncertain or anxious about the legal implications of sharing information, particularly in complex or high-risk cases. This persistent uncertainty underscores the need for more strategic and politically driven leadership to provide clear, consistent guidance and reassurance. Without such direction, frontline staff may default to risk-averse behaviours that hinder collaborative working and the integration of care. Addressing these barriers requires not only technical solutions but also cultural and systemic change—where legal literacy, interprofessional trust, and shared accountability are actively cultivated. Such an approach is consistent with relational coordination theory, which emphasises the role of shared goals, mutual respect, and effective communication in fostering confident and collaborative decision-making [26].

The findings from this study highlight the importance of trusting relationships between ED staff and OWs as a key mechanism enabling the effective use of the Trigger Checklist. When OWs possess high situational awareness, they can judge the right moment and approach for engaging ED staff, which is only possible when mutual respect and trust are present. This aligns with broader realist evaluation literature, which consistently identifies trust as a generative mechanism in inter-organisational and inter-professional collaborations. For example, Aunger et al [37] describe trust, confidence, and faith as foundational to knowledge sharing and joint decision-making across healthcare sectors. Similarly, realist evaluations of integrated care and first-contact physiotherapy services show that trust between staff from different departments or agencies facilitates role acceptance, adaptive behaviour, and improved service delivery. In this study, trust not only enabled knowledge exchange between OWs and ED staff but also created the conditions for collaborative discussion and action that ultimately benefited individuals at risk of drug-related harm. These findings suggest that trust-building should be an explicit focus in programme design and implementation, particularly where complexity and uncertainty are high where relational mechanisms are crucial for sustained engagement and impact.

This study found that ED staff were more inclined to complete the Trigger Checklist when they felt an intrinsic motivation to support individuals at risk of drug-related harm—particularly when they perceived the checklist as a meaningful tool that extended their impact beyond standard emergency care. Staff reported increased motivation when they observed reductions in repeat attendances and received narrative feedback from OWs about individuals who had been successfully supported. These findings suggest that intrinsic motivation—rooted in professional values, empathy, and a desire to make a difference—is a more powerful driver of engagement than extrinsic motivators such as performance metrics or data dashboards. In fact, few staff found data displays motivating; some even felt that an overemphasis on data diminished the perceived value of the intervention by shifting focus away from person-centred outcomes. This aligns with realist literature that emphasises the importance of aligning programme mechanisms with the internal reasoning and values of participants. For interventions like the Trigger Checklist to be sustained and effective, it is crucial to nurture intrinsic motivation through relational feedback, storytelling, and visible impact, rather than relying solely on quantitative indicators.

While this realist evaluation was conducted in a single remote and rural location, which may limit generalisability, the emphasis in realist methodology is on transferability. The findings may be applicable to similar contexts where comparable mechanisms and conditions exist. Realist theory development is inherently iterative, and further studies in diverse settings are needed to affirm, refine, or refute the programme theories developed here. In addition, the Trigger Checklist used to identify people at risk of drug harm was developed pragmatically through collaboration between Drug and Alcohol practitioners and individuals with lived experience. Formal evaluation of the checklist’s sensitivity and specificity was beyond the scope of this work. Although all referrals were reviewed by a Drug and Alcohol Practitioner prior to outreach and very few were subsequently deemed inappropriate, future research should formally examine the performance characteristics of the checklist and explore how different referral thresholds may influence identification and engagement.

A further limitation of this study is that the final programme theories were not reviewed by the Project Advisory Group or study participants due to time constraints and service pressures. However, they were iteratively refined using data from those delivering and experiencing the intervention throughout the project. Informal feedback following dissemination of the findings to practitioners and individuals supporting Drug and Alcohol services indicated that the findings resonated with their experiences. Nevertheless, further formal stakeholder input would strengthen confidence in the proposed context–mechanism–outcome explanations and should be incorporated in future studies.

Conclusion

This study provides theory-informed insights into implementing a pathway that connects individuals at risk of drug-related harm in EDs with recovery services. By identifying key context–mechanism–outcome patterns, it deepens understanding of how relational and contextual dynamics shape frontline implementation. Relational coordination emerged as a critical aspect to bridge disconnected services and enable timely referrals. These findings confirm and extend existing theory on inter-service collaboration and can inform future adaptations and scaling strategies that remain responsive to local conditions and staff reasoning.

Supporting information

S1 File. Initial CMOs to final CMOs.

(DOCX)

pone.0358880.s001.docx (33.5KB, docx)
S2 File. Topic guide for stakeholders interview.

(DOCX)

pone.0358880.s002.docx (18.9KB, docx)
S1 Fig. Conceptual framework.

(TIF)

pone.0358880.s003.tif (86.6KB, tif)
S1 Table. CMO configurations and exemplar quotations.

(DOCX)

pone.0358880.s004.docx (27.4KB, docx)

Acknowledgments

We gratefully acknowledge the generosity of the Emergency Department staff, who gave their time and willingly participated in interviews. We also extend our thanks to the recovery service staff, whose interest and support were instrumental in overcoming barriers to recruitment.

Data Availability

Although the dataset was anonymised prior to analysis, there remains a potential risk of participant re- identification due to the small size of the rural communities included in the study. Several participants occupy specific professional or community roles that are held by one or a small number of individuals within these communities. As a result, the sharing of even de-identified qualitative data could inadvertently enable identification of participants when combined with contextual information. The study was conducted under ethical approval granted by the University of the Highlands and Islands Ethics Committee (ID: ETH2425-0561), and participants provided informed consent on the understanding that their information would remain confidential. The approved participant information and consent form stated: “I understand that any information recorded in the interview will remain confidential and no information that identifies me as an individual will be made publicly available.” Making the dataset publicly available would therefore be inconsistent with the assurances of confidentiality provided to participants and approved by the Ethics Committee. For these ethical reasons, we do not consider public sharing of the dataset to be appropriate. If you have any further questions or wish to contact an independent person to whom any questions may be directed, please contact: UHI Research Ethics Officer University of the Highlands and Islands Research Ethics Committee (REC) University of the Highlands and Islands, 12b Ness Walk, Inverness, IV3 5SQ. Telephone: 00 441463-279349 Email: research.ethics@uhi.ac.uk.

Funding Statement

This study was funded through Q Exchange by the Health Foundation and NHS England. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  • 1.World Health Organization. Opioid overdose. 2025. [cited 2025]. Available from: https://www.who.int/news-room/fact-sheets/detail/opioid-overdose
  • 2.Onohuean H, Oosthuizen F. The burden of unlawful use of opioid and associated epidemiological characteristics in Africa: A scoping review. PLoS One. 2025;20(3):e0317036. doi: 10.1371/journal.pone.0317036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.National Records of Scotland. Drug-related deaths in Scotland, 2024 2025. 2024. Available from: https://www.nrscotland.gov.uk/publications/drug-related-deaths-in-scotland-2024/#scotland
  • 4.McAuley A, Fraser R, Glancy M, Yeung A, Jones HE, Vickerman P, et al. Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011: a national retrospective cohort study. The Lancet Public Health. 2023;8(7):e484–93. doi: 10.1016/S2468-2667(23)00082-8 [DOI] [PubMed] [Google Scholar]
  • 5.Audit Scotland. Alcohol and drug services. 2024. [cited 11/12/25]. Available from: https://audit.scot/uploads/2024-10/nr_241031_drugs_alcohol.pdf
  • 6.European Monitoring Centre for Drugs and Drug Addiction EMCDDA. European Drug Report 2024: Trends and Developments. 2024. [cited 11/12/25]. Available from: https://www.euda.europa.eu/publications/european-drug-report/2024_en
  • 7.Government of Canada. The Canadian Drugs Substances Strategy: The Government of Canada’s Approach to Substance Use Related Harms and the Overdose Crisis. Ottawa: Government of Canada. 2023. [Google Scholar]
  • 8.UK Government. All Our Health: About the Programme. Office for Health Improvement and Disparities. 2024. Available from: https://www.gov.uk/government/publications/all-our-health-about-the-framework/all-our-health-about-the-framework [Google Scholar]
  • 9.Scottish Government. Medication Assisted Treatment (MAT) standards: access, choice, support. 2021. [cited 2023]. Available from: https://www.gov.scot/publications/medication-assisted-treatment-mat-standards-scotland-access-choice-support/
  • 10.Cambridge G, Kynch O, Windle J. The desistance journey: Into recovery and out of chaos. Cham: Palgrave Macmillan. 2022. [Google Scholar]
  • 11.Mahboub N, Honein-AbouHaidar G, Rizk R, de Vries N. People who use drugs in rehabilitation, from chaos to discipline: Advantages and pitfalls: A qualitative study. PLoS One. 2021;16(2):e0245346. doi: 10.1371/journal.pone.0245346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Davis S, Wallace B, Van Roode T, Hore D. Substance Use Stigma and Community Drug Checking: A Qualitative Study Examining Barriers and Possible Responses. Int J Environ Res Public Health. 2022;19(23):15978. doi: 10.3390/ijerph192315978 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Manurung L. The Impact of Drug Abuse on Families and Society (Literature Review). MSJ. 2024;2(2):239–44. doi: 10.61942/msj.v2i2.168 [DOI] [Google Scholar]
  • 14.Sibley AL, Klein E, Cooper HLF, Livingston MD 3rd, Baker R, Walters SM, et al. The relationship between felt stigma and non-fatal overdose among rural people who use drugs. Harm Reduct J. 2024;21(1):77. doi: 10.1186/s12954-024-00988-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pinkhover A, Celata K, Baker T, Chatterjee A, Lunze K. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit. Front Public Health. 2024;12:1407522. doi: 10.3389/fpubh.2024.1407522 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Owczarzak J, Martin E, Weicker N, Evans I, Morris M, Sherman SG. A qualitative exploration of harm reduction in practice by street-based peer outreach workers. Harm Reduct J. 2024;21(1):161. doi: 10.1186/s12954-024-01076-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Parkes T, Matheson C, Carver H, Foster R, Budd J, Liddell D, et al. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study. Health Technol Assess. 2022;26(14):1–128. doi: 10.3310/WVVL4786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Campbell L, Fraser B, Beattie M. Reducing drug-related harm by triggering proactive outreach. BMJ Open Qual. 2025;14(4):e003524. doi: 10.1136/bmjoq-2025-003524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nambiar D, Spelman T, Stoové M, Dietze P. Are people who inject drugs frequent users of emergency department services? A cohort study (2008-2013). Subst Use Misuse. 2018;53(3):457–65. doi: 10.1080/10826084.2017.1341921 [DOI] [PubMed] [Google Scholar]
  • 20.Pawson RATN. Reaistic evaluation. Sage Publications. 1997. [Google Scholar]
  • 21.Greenhalgh J, Manzano A. Understanding ‘context’ in realist evaluation and synthesis. International Journal of Social Research Methodology. 2021;25(5):583–95. doi: 10.1080/13645579.2021.1918484 [DOI] [Google Scholar]
  • 22.Manzano A. The craft of interviewing in realist evaluation. Evaluation. 2016;22(3):342–60. doi: 10.1177/1356389016638615 [DOI] [Google Scholar]
  • 23.Scottish Government. National Drugs Mission Plan: 2022-2026. 2022. Available from: https://www.gov.scot/publications/national-drugs-mission-plan-2022-2026/pages/3/
  • 24.Manhica H, Straatmann VS, Lundin A, Agardh E, Danielsson A-K. Association between poverty exposure during childhood and adolescence, and drug use disorders and drug-related crimes later in life. Addiction. 2021;116(7):1747–56. doi: 10.1111/add.15336 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.NHS Highland. Caithness Partnership Profile: Adult Health and Wellbeing. NHS Highland Public Health Intelligence. 2023. Available from: https://www.nhshighland.scot.nhs.uk/media/yrui0hxm/adulthealth-caithness-2023.pdf [Google Scholar]
  • 26.Hoffer Gittell J. Coordinating Mechanisms in Care Provider Groups: Relational Coordination as a Mediator and Input Uncertainty as a Moderator of Performance Effects. Management Science. 2002;48(11):1408–26. doi: 10.1287/mnsc.48.11.1408.268 [DOI] [Google Scholar]
  • 27.UK Government. The Caldicott Principles. 2010. [cited 2025 December 15]. Available from: https://www.gov.uk/government/publications/the-caldicott-principles
  • 28.Zani CM, de Moura PK, dos Santos BM, Saurin TA. Visual Management in Healthcare: A Systematic Literature Review of Main Practices and Applications. Zani CM, de Moura PK, dos Santos BM, Saurin TA, editors. Cham: Springer International Publishing. 2020. [Google Scholar]
  • 29.Maaz S, Palaganas JC, Palaganas G, Bajwa M. A guide to prompt design: foundations and applications for healthcare simulationists. Front Med (Lausanne). 2025;11:1504532. doi: 10.3389/fmed.2024.1504532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Zwaan L, Staal J. Evidence on use of clinical reasoning checklists for diagnostic error reduction. Agency for Healthcare Research and Quality. 2020. [cited 2025 December 11]. Available from: https://www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/diagnostic-error-reduction.pdf
  • 31.Wan J. Evidence-based practice and health informatics: enhancing care quality. J Evid Based Med Healthc. 2024;11(2):1–2. doi: 10.18410/jebmh/2024/11/02/115 [DOI] [Google Scholar]
  • 32.Goetz K, Oldenburg D, Strobel CJ, Steinhäuser J. The influence of fears of perceived legal consequences on general practitioners’ practice in relation to defensive medicine - a cross-sectional survey in Germany. BMC Prim Care. 2024;25(1):23. doi: 10.1186/s12875-024-02267-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Strobel CJ, Oldenburg D, Steinhäuser J. Factors influencing defensive medicine-based decision-making in primary care: A scoping review. J Eval Clin Pract. 2023;29(3):529–38. doi: 10.1111/jep.13799 [DOI] [PubMed] [Google Scholar]
  • 34.Li X, Cong Y. Exploring barriers and ethical challenges to medical data sharing: perspectives from Chinese researchers. BMC Med Ethics. 2024;25(1):132. doi: 10.1186/s12910-024-01135-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hogg-Graham R, Scott AM, Clear ER, Riley EN, Waters TM. Technology, data, people, and partnerships in addressing unmet social needs within Medicaid Managed Care. BMC Health Serv Res. 2024;24(1):368. doi: 10.1186/s12913-024-10705-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kludacz-Alessandri M, Hawrysz L, Żak K, Zhang W. The impact of digital transformational leadership on digital intensity among primary healthcare entities: a moderated mediation model. BMC Health Serv Res. 2025;25(1):117. doi: 10.1186/s12913-025-12283-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Aunger JA, Millar R, Greenhalgh J. When trust, confidence, and faith collide: refining a realist theory of how and why inter-organisational collaborations in healthcare work. BMC Health Serv Res. 2021;21(1):602. doi: 10.1186/s12913-021-06630-x [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Maria Berghs

7 Jul 2026

Implementation of the Trigger Checklist and Assertive Outreach to Reduce Drug-Related Harm in the Emergency Department: A Realist Evaluation

PLOS One

Dear Dr. Beattie,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers are supportive and have asked for some minor revisions to strengthen the paper. I trust the authors can move forwards in addressing these remarks.

Please submit your revised manuscript by Aug 21 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Maria J Berghs, PhD

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

3. Thank you for stating the following financial disclosure:

“This study was funded through Q Exchange by the Health Foundation and NHS England”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Many thanks for the opportunity to review this manuscript.

Noting the critically of being able to identify those most at risk of drug related deaths / overdose situations, the authors have developed a ‘trigger checklist’ to estimate the extent of risk in real time and as a practical tool for pro-active assertive outreach in this instance in the ED setting. Given an earlier demonstration of the checklists likely positive impact in community settings, it is a very understandable attempt to elucidate why ED teams showed a relatively low application of the list. There is also the added complexity of the relatively rural setting.

The CMO methodology is appropriate (for ‘setting specific’ evaluations) and well described as are the emergent theories in the results section. The checklists relative simplicity and low threshold (or high sensitivity) are to be commended, though it would be useful to know if the investigators attempted any form of sensitivity analysis (even in the abstract where the likely impact of increasing and deceasing sensitivity might be considered). The extrapolation that 3/4s of those using drugs in the area were not known engaged with services served to further highlight the importance of the project.

Overall, the report presents a very engaging and practical narrative and serves to highlight the sort of actions that are important (relationships unsurprisingly). It is the very context specificity of the benefits (which the authors by no means shy away from) including the variable attitudes to consent which raise the most questions about wider generalisability. Having refined their methods in the course of looking at this setting therefore the authors are well placed to look at generalisability to other settings and other regions (e.g. the larger central belt populations), where the stigma of limited anonymity is less prevalent, but would the relative patient numbers result in a prohibitive work-load in the short term?.

Lastly have the authors considered adapting the tool for prison and justice settings?

Reviewer #2: Thank you for the opportunity to review this realist evaluation of relating to the evaluation of the use of a Trigger Checklist in a rural ED in Scotland. For transparency, I am a qualitative researcher who is familiar with realist methods.

I found the paper clearly written and carefully planned and presented. The aim is clearly stated, and I find that this is well answered by the analysis. I have no ethical concerns.

The ‘problem’ the study is addressing, and the potential transferability and relevance of the work to other contexts, is made clear in the introduction. Moreover, the CMO configurations are presented at a level of detail that is appropriate and useful to allow application to other contexts. The transferability is particularly supported by the use of relational coordination theory.

Realist evaluation is an appropriate methodological choice for the aims of the work. This appears to have been conducted rigorously. The information provided in the Results aligns with the realist analysis process described in the methods. This is appropriately supported by the appendices I’d like to see with a realist review.

I have two small suggestions for improvement:

1. The use of a Project Advisory Group to develop initial programme theories was a strength – was this group consulted to comment on refined/final theories? (Or perhaps the study participants?) If so, please could this be made clear in the paper, and if not, I suggest you discuss this as a limitation. Confirmation from those who understand the lived experience of the intervention is important in realist work and would strengthen the credibility of conclusions.

2. I note the team is (appropriately) a mix of clinical and academic staff. Given the number of subjective decisions necessary within such a review (especially during testing the CMOs), you might consider a short section on team reflexivity to help the reader situate the analysis and aid transparency about how the researchers reduced bias and used reflexive practice in the analytical process.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Oct 5;21(10):e0358880. doi: 10.1371/journal.pone.0358880.r002

Author response to Decision Letter 1


14 Aug 2026

7th August 2026

Dear Professor Berghs

Manuscript ID PONE-D-25-67347 Implementation of the Trigger Checklist and Assertive Outreach to Reduce Drug-Related Harm in the Emergency Department: A Realist Evaluation

Thank you very much for coordinating the further revision of our manuscript, which we hope will be considered for publication in PLOS ONE.

Please find details of responses to reviewer’s and editorial comments below.

Editorial Comments

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response

All formatting updated in accordance with the Manuscript Body Formatting Guidelines and Title, Author, Affiliations Formatting Guidelines.

2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

Response

The Funding Statement has been removed from the manuscript.

3. Thank you for stating the following financial disclosure: “This study was funded through Q Exchange by the Health Foundation and NHS England”

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

Response

This study was funded through Q Exchange by the Health Foundation and NHS England (statement removed from main manuscript). Role of Funder for online submission “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

4. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Response

Although the dataset was anonymised prior to analysis, there remains a potential risk of participant re-identification due to the small size of the rural communities included in the study. Several participants occupy specific professional or community roles that are held by one or a small number of individuals within these communities. As a result, the sharing of even de-identified qualitative data could inadvertently enable identification of participants when combined with contextual information. The study was conducted under ethical approval granted by the University of the Highlands and Islands Ethics Committee (ID: ETH2425-0561), and participants provided informed consent on the understanding that their information would remain confidential. The approved participant information and consent form stated:

“I understand that any information recorded in the interview will remain confidential and no information that identifies me as an individual will be made publicly available.”

Making the dataset publicly available would therefore be inconsistent with the assurances of confidentiality provided to participants and approved by the Ethics Committee. For these ethical reasons, we do not consider public sharing of the dataset to be appropriate.

If you have any further questions or wish to contact an independent person to whom any questions may be directed, please contact:

UHI Research Ethics Officer

University of the Highlands and Islands Research Ethics Committee (REC)

University of the Highlands and Islands, 12b Ness Walk, Inverness, IV3 5SQ.

Telephone: 00 441463-279349

Email: research.ethics@uhi.ac.uk

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. No recommendation to cite specific work in reviewers’ feedback.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response

References are complete and correct.

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Response

The figure has been reformatted to meet the journal requirements using NASS.

Reviewer 1 Comments

The checklists relative simplicity and low threshold (or high sensitivity) are to be commended, though it would be useful to know if the investigators attempted any form of sensitivity analysis (even in the abstract where the likely impact of increasing and deceasing sensitivity might be considered). The extrapolation that 3/4s of those using drugs in the area were not known engaged with services served to further highlight the importance of the project.

Reviewer 1 Responses

We thank the reviewer for this observation. The Trigger Checklist was developed pragmatically through collaboration between experienced Drug and Alcohol practitioners and individuals with lived experience of recovery, with the primary aim of maximising identification of potentially vulnerable individuals who may benefit from outreach. A formal sensitivity analysis was not undertaken as part of this service evaluation/project, and we acknowledge this as a limitation. However, all completed Trigger Checklists were reviewed by a qualified Drug and Alcohol Practitioner prior to outreach activity to assess appropriateness and risk. Practitioner feedback indicated that only a very small number of referrals (fewer than five cases during the project) were subsequently considered unsuitable for outreach. While these observations do not constitute a formal assessment of sensitivity or specificity, they suggest that the checklist functioned as intended in identifying individuals potentially in need of engagement. We have added text to the manuscript acknowledging the absence of formal sensitivity analysis and recommending this as an important area for future evaluation of the checklist (see lines 658-666).

Having refined their methods in the course of looking at this setting therefore the authors are well placed to look at generalisability to other settings and other regions (e.g. the larger central belt populations), where the stigma of limited anonymity is less prevalent, but would the relative patient numbers result in a prohibitive work-load in the short term?

Response

We thank the reviewer for this observation. From a realist perspective, we would not necessarily expect the same context–mechanism–outcome configurations to operate in different settings. Rather, future work would test whether mechanisms identified in this study, such as the value of relational outreach, trust-building, and concerns regarding information sharing, remain important under different contextual conditions. While issues relating to anonymity and stigma may be less pronounced in larger urban populations, alternative contextual influences may become more important. We also agree that feasibility warrants exploration. The continuation of the service in this area was facilitated through organisational reconfiguration and the subsequent creation of two outreach worker posts. Urban areas may face different workforce and capacity challenges due to higher referral volumes, making evaluation of scalability and resource requirements an important next phase of testing and refinement. A quality improvement project is currently underway to test implementation of the Trigger Checklist within an urban Emergency Department setting, which may provide valuable insights into capacity requirements and inform our next realist study.

Reviewer 2 Comments

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Response

See response to point 4 of the editorial comments.

1. The use of a Project Advisory Group to develop initial programme theories was a strength – was this group consulted to comment on refined/final theories? (Or perhaps the study participants?) If so, please could this be made clear in the paper, and if not, I suggest you discuss this as a limitation. Confirmation from those who understand the lived experience of the intervention is important in realist work and would strengthen the credibility of conclusions.

Reviewer 2 Responses

We thank the reviewer for this important observation. The Project Advisory Group was involved in the development and refinement of the initial programme theories; however, the refined and final programme theories were not subsequently presented to the group. This was primarily due to time constraints within the project and challenges securing participation from clinical staff given competing service demands. We agree that stakeholder validation of refined programme theories can enhance the credibility of realist findings and provide an opportunity to assess the resonance of interpretations with lived and professional experience. We have therefore acknowledged the absence of final theory refinement with the Project Advisory Group as a limitation and recommend this as an important component of future realist evaluations. See lines 667-675 in the discussion section.

2. I note the team is (appropriately) a mix of clinical and academic staff. Given the number of subjective decisions necessary within such a review (especially during testing the CMOs), you might consider a short section on team reflexivity to help the reader situate the analysis and aid transparency about how the researchers reduced bias and used reflexive practice in the analytical process.

Response

We thank the reviewer for this valuable suggestion. Reflexive discussions were embedded throughout the analysis, although this was not sufficiently described in the manuscript. The multidisciplinary team, comprising academic and clinical members, met weekly during analysis to discuss emerging findings, challenge interpretations, and refine programme theories and CMO configurations. Particular emphasis was placed on retroductive reasoning, with team members debating plausible underlying mechanisms and alternative explanations for observed outcomes. These discussions supported reflexivity, consensus-building, and consideration of different professional perspectives. We have now added a short reflexivity section to the manuscript (see line 269-276 in methods).

We are grateful for the feedback and believe it has improved our paper.

We look forward to hearing from you.

Sincerely,

Dr Michelle Beattie

On behalf of DR HOPE Team

Attachment

Submitted filename: DRHOPE_ResponseReviewers_July26.doc

pone.0358880.s006.doc (73.5KB, doc)

Decision Letter 1

Maria Berghs

8 Sep 2026

Implementation of the Trigger Checklist and Assertive Outreach to Reduce Drug-Related Harm in the Emergency Department: A Realist Evaluation

PONE-D-25-67347R1

Dear Dr. Beattie,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Maria J Berghs, PhD

Academic Editor

PLOS One

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: (No Response)

**********

Reviewer #2: The authors have effectively addressed the feedback I raised in my earlier review and have made relevant changes to the paper.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

**********

Acceptance letter

Maria Berghs

PONE-D-25-67347R1

PLOS One

Dear Dr. Beattie,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS One and supporting open access.

Kind regards,

PLOS One Editorial Office Staff

on behalf of

Dr. Maria J Berghs

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Initial CMOs to final CMOs.

    (DOCX)

    pone.0358880.s001.docx (33.5KB, docx)
    S2 File. Topic guide for stakeholders interview.

    (DOCX)

    pone.0358880.s002.docx (18.9KB, docx)
    S1 Fig. Conceptual framework.

    (TIF)

    pone.0358880.s003.tif (86.6KB, tif)
    S1 Table. CMO configurations and exemplar quotations.

    (DOCX)

    pone.0358880.s004.docx (27.4KB, docx)
    Attachment

    Submitted filename: DRHOPE_ResponseReviewers_July26.doc

    pone.0358880.s006.doc (73.5KB, doc)

    Data Availability Statement

    Although the dataset was anonymised prior to analysis, there remains a potential risk of participant re- identification due to the small size of the rural communities included in the study. Several participants occupy specific professional or community roles that are held by one or a small number of individuals within these communities. As a result, the sharing of even de-identified qualitative data could inadvertently enable identification of participants when combined with contextual information. The study was conducted under ethical approval granted by the University of the Highlands and Islands Ethics Committee (ID: ETH2425-0561), and participants provided informed consent on the understanding that their information would remain confidential. The approved participant information and consent form stated: “I understand that any information recorded in the interview will remain confidential and no information that identifies me as an individual will be made publicly available.” Making the dataset publicly available would therefore be inconsistent with the assurances of confidentiality provided to participants and approved by the Ethics Committee. For these ethical reasons, we do not consider public sharing of the dataset to be appropriate. If you have any further questions or wish to contact an independent person to whom any questions may be directed, please contact: UHI Research Ethics Officer University of the Highlands and Islands Research Ethics Committee (REC) University of the Highlands and Islands, 12b Ness Walk, Inverness, IV3 5SQ. Telephone: 00 441463-279349 Email: research.ethics@uhi.ac.uk.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES